Boguslaw Szczupak

Dr. Boguslaw Szczupak

Telecommunications and Teleinformatics, Wroclaw University of Science and Technology, Wrocław, Dolnośląskie, Poland
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2017 in Nanoscale
Verified
Journal Article
Open access
PDF file
Javier RegueraJavier Reguera
Javier Reguera
DADorleta Jimenez De Aberasturi
Dorleta Jimenez De Aberasturi
MHMalou Henriksen-Lacey
Malou Henriksen-Lacey
JLJudith Langer
Judith Langer
AEAna Espinosa
Ana Espinosa
LLLuis M. Liz-Marzán
Luis M. Liz-Marzán
Janus Au–Fe3O4 star-sphere nanoparticles show their high versatility as contrast agents in multimodal imaging.

18 July 2014 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
FSFederico Soria
Federico Soria
APAlberto Pérez-Samartín
Alberto Pérez-Samartín
AMAbraham Martin
Abraham Martin
KGKiran Babu Gona
Kiran Babu Gona
JLJordi Llop
Jordi Llop
MDMaria Domercq
Maria Domercq
During brain ischemia, an excessive release of glutamate triggers neuronal death through the overactivation of NMDA receptors (NMDARs); however, the underlying pathways that alter glutamate homeostasis and whether synaptic or extrasynaptic sites are responsible for excess glutamate remain controversial. Here, we monitored ischemia-gated currents in pyramidal cortical neurons in brain slices from rodents in response to oxygen and glucose deprivation (OGD) as a real-time glutamate sensor to identify the source of glutamate release and determined the extent of neuronal damage. Blockade of excitatory amino acid transporters or vesicular glutamate release did not inhibit ischemia-gated currents or neuronal damage after OGD. In contrast, pharmacological inhibition of the cystine/glutamate antiporter dramatically attenuated ischemia-gated currents and cell death after OGD. Compared with control animals, mice lacking a functional cystine/glutamate antiporter exhibited reduced anoxic depolarization and neuronal death in response to OGD. Furthermore, glutamate released by the cystine/glutamate antiporter activated extrasynaptic, but not synaptic, NMDARs, and blockade of extrasynaptic NMDARs reduced ischemia-gated currents and cell damage after OGD. Finally, PET imaging showed increased cystine/glutamate antiporter function in ischemic rats. Altogether, these data suggest that cystine/glutamate antiporter function is increased in ischemia, contributing to elevated extracellular glutamate concentration, overactivation of extrasynaptic NMDARs, and ischemic neuronal death.

22 June 2018 in Nanoscale
Verified
Journal Article
Open access
PDF file
VGVanessa Gómez-Vallejo
Vanessa Gómez-Vallejo
MPMaría Puigivila
María Puigivila
SPSandra Plaza-García
Sandra Plaza-García
BSBoguslaw Szczupak
Boguslaw Szczupak
RLRafael Piñol Lacambra
Rafael Piñol Lacambra
AMAngel Millan
Angel Millan
In vitro experiments have shown the great potential of magnetic nanocarriers for multimodal imaging diagnosis and non-invasive therapies. However, their extensive clinical application is still jeopardized by a fast retention in the reticuloendothelial system (RES). The other issue that restrains their potential performance is slow degradation and excretion, which increases their risks of toxicity. We report a promising case in which multicore iron oxide nanoparticles coated with a poly(4-vinylpyridine) polyethylene glycol copolymer show low RES retention and high urinary excretion, as confirmed by single photon emission computerized tomography (SPECT), gamma counting, magnetic resonance imaging (MRI) and electron microscopy (EM) biodistribution studies. These iron oxide-copolymer nanoparticles have a high PEG density in their coating which may be responsible for this effect. Moreover, they show a clear negative contrast in the MR imaging of the kidneys. These nanoparticles with an average hydrodynamic diameter of approximately 20 nm were nevertheless able to cross the glomerulus wall which has an effective pore size of approximately 6 nm. A transmission electron microscopy inspection of kidney tissue revealed the presence of iron containing nanoparticle clusters in proximal tubule cells. This therefore makes them exceptionally useful as magnetic nanocarriers and as new MRI contrast agents for the kidneys.

1 September 2015 in Journal of Controlled Release
Verified
Journal Article
Closed access
IRI. Rosenberger
I. Rosenberger
ASA. Strauss
A. Strauss
SDS. Dobiasch
S. Dobiasch
CWC. Weis
C. Weis
SSS. Szanyi
S. Szanyi
MJM. Jiménez-González
M. Jiménez-González

21 September 2016 in Biomacromolecules
Verified
Journal Article
Open access
ABAna B. Benito
Ana B. Benito
MAMiren K. Aiertza
Miren K. Aiertza
MMMarco Marradi
Marco Marradi
LGLarraitz Gil-Iceta
Larraitz Gil-Iceta
TZTalia Shekhter Zahavi
Talia Shekhter Zahavi
ILIraida Loinaz
Iraida Loinaz
The development of tools for the early diagnosis of pancreatic adenocarcinoma is an urgent need in order to increase treatment success rate and reduce patient mortality. Here, we present a modular nanosystem platform integrating soft nanoparticles with a targeting peptide and an active imaging agent for diagnostics. Biocompatible single-chain polymer nanoparticles (SCPNs) based on poly(methacrylic acid) were prepared and functionalized with the somatostatin analogue PTR86 as the targeting moiety, since somatostatin receptors are overexpressed in pancreatic cancer. The gamma emitter 67Ga was incorporated by chelation and allowed in vivo investigation of the pharmacokinetic properties of the nanoparticles using single photon emission computerized tomography (SPECT). The resulting engineered nanosystem was tested in a xenograph mouse model of human pancreatic adenocarcinoma. Imaging results demonstrate that accumulation of targeted SCPNs in the tumor is higher than that observed for nontargeted nanoparticles due to improved retention in this tissue.

1 January 2016 in Theranostics
Verified
Journal Article
Open access
MDMaria Domercq
Maria Domercq
BSBoguslaw Szczupak
Boguslaw Szczupak
JGJon Gejo
Jon Gejo
VGVanessa Gómez-Vallejo
Vanessa Gómez-Vallejo
DPDaniel Padro
Daniel Padro
AMAbraham Martin
Abraham Martin
In vivo Positron Emission Tomography (PET) imaging of the cystine-glutamate antiporter (system xc-) activity with [18F]FSPG is meant to be an attractive tool for the diagnosis and therapy evaluation of brain diseases. However, the role of system xc- in cerebral ischemia and its involvement in inflammatory reaction has been scarcely explored. In this work, we report the longitudinal investigation of the neuroinflammatory process following transient middle cerebral artery occlusion (MCAO) in rats using PET with [18F]FSPG and the translocator protein (TSPO) ligand [18F]DPA-714. In the ischemic territory, [18F]FSPG showed a progressive binding increase that peaked at days 3 to 7 and was followed by a progressive decrease from days 14 to 28 after reperfusion. In contrast, [18F]DPA-714 evidenced maximum binding uptake values over day 7 after reperfusion. Ex vivo immnunohistochemistry confirmed the up-regulation of system xc- in microglial cells and marginally in astrocytes. Inhibition of system xc- with sulfasalazine and S-4-CPG resulted in increased arginase (anti-inflammatory M2 marker) expression at day 7 after ischemia, together with a decrease in TSPO and microglial M1 proinflammatory markers (CCL2, TNF and iNOS) expression. Taken together, these results suggest that system xc- plays a key role in the inflammatory reaction underlying experimental stroke.